Clinical trial Recruiting at 1 site Observational Ages 18 to 45 Women only

Maternal thyroid function and anxiety in high-risk pregnancies and their links to fetal heart activity

Official title: Association Between Maternal Thyroid Functions, Anxiety Levels, and Fetal Cardiotocography Parameters in High-Risk Pregnancies

Run by Istanbul Training and Research Hospital · NCT07774949 · Data updated 2026-11-12

This study will see if maternal thyroid levels and anxiety levels relate to how a fetus’s heart responds during a routine NST in pregnancies at high risk.

Quick facts

Study typeObservational
Ages18 Years to 45 Years
SexWomen only
Enrollment150 (estimated)
SponsorIstanbul Training and Research Hospital
Government
Locations1 site (Istanbul)
StatusRecruiting
StartedMarch 27, 2026
Main results expectedApril 2028
Study endsDecember 2028
Registry record updatedAugust 19, 2026
Trial IDNCT07774949 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Pregnant individuals with singleton gestations at 32 weeks or later, classified as high-risk and receiving routine thyroid testing and NST in the perinatology clinic, aged 18–45.

Probably not a fit

Patients outside the 32 weeks or later window or with multiple pregnancies, acute obstetric conditions, or current psychiatric treatment may not experience any study-derived benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational study enrolled pregnant women at 32 weeks or later who are managed as high-risk in a perinatology clinic. Researchers will collect routine thyroid test results (TSH and free T4) and assess maternal anxiety using the Beck Anxiety Inventory, alongside a standard 20-minute non-stress test of the fetus. They will analyze how maternal thyroid status and anxiety relate to fetal cardiotocography parameters such as baseline heart rate, accelerations, reactivity, and decelerations, while considering sociodemographic and obstetric factors. The goal is to identify associations that might help understand fetal well-being in high-risk pregnancies. No interventions are being tested; the study is observational and relies on routine clinical data and non-invasive fetal monitoring.

Why it matters

Potential benefit: If associations are found, clinicians may better interpret fetal monitoring in relation to maternal thyroid status and anxiety in high-risk pregnancies.

How similar studies have gone: Prior work has explored links between maternal thyroid function, anxiety, and fetal monitoring in various contexts, but this specific combination in high-risk pregnancies is exploratory and adds novel observational insight.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Singleton pregnancy at 32 weeks of gestation or later
* Pregnancy being followed as a high-risk pregnancy
* Age between 18 and 45 years
* Availability of routine thyroid function test results and non-stress test assessment
* Ability and willingness to provide written informed consent

Exclusion Criteria:

* Gestational age below 32 weeks
* Multiple pregnancy
* Fetal conditions that may affect interpretation of the non-stress test tracing
* Acute maternal infection
* Presence of an acute obstetric condition
* Previously diagnosed psychiatric disorder
* Current use of psychiatric medication
* Age younger than 18 years or older than 45 years

Where it's running

  • Istanbul Training and Research Hospital
    Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.